Comgest Global Investors S.A.S. lessened its stake in Aramark (NYSE:ARMK) by 13.2% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 114,900 shares of the company’s stock after selling 17,500 shares during the quarter. Comgest Global Investors S.A.S.’s holdings in Aramark were worth $4,666,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the stock. CAPROCK Group Inc. raised its stake in Aramark by 0.8% in the second quarter. CAPROCK Group Inc. now owns 5,528 shares of the company’s stock valued at $227,000 after purchasing an additional 43 shares in the last quarter. Pitcairn Co. grew its position in Aramark by 3.2% in the second quarter. Pitcairn Co. now owns 8,330 shares of the company’s stock valued at $341,000 after acquiring an additional 255 shares during the last quarter. Pacer Advisors Inc. grew its position in Aramark by 8.3% in the second quarter. Pacer Advisors Inc. now owns 4,871 shares of the company’s stock valued at $200,000 after acquiring an additional 374 shares during the last quarter. Howard Hughes Medical Institute grew its position in Aramark by 0.7% in the second quarter. Howard Hughes Medical Institute now owns 57,423 shares of the company’s stock valued at $2,353,000 after acquiring an additional 382 shares during the last quarter. Finally, Utah Retirement Systems grew its position in Aramark by 0.9% in the second quarter. Utah Retirement Systems now owns 44,500 shares of the company’s stock valued at $1,824,000 after acquiring an additional 400 shares during the last quarter. 93.75% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: This report was originally posted by Daily Political and is the sole property of of Daily Political. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://www.dailypolitical.com/2017/11/15/comgest-global-investors-s-a-s-has-4-67-million-position-in-aramark-armk.html.

Aramark (NYSE ARMK) traded down $2.83 during trading hours on Wednesday, hitting $40.02. The stock had a trading volume of 5,946,500 shares, compared to its average volume of 1,389,833. The company has a market capitalization of $10,506.43, a PE ratio of 24.78, a P/E/G ratio of 1.78 and a beta of 0.50. The company has a debt-to-equity ratio of 2.34, a quick ratio of 1.00 and a current ratio of 1.30. Aramark has a 52 week low of $32.73 and a 52 week high of $44.12.

Aramark (NYSE:ARMK) last released its quarterly earnings results on Tuesday, November 14th. The company reported $0.54 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.02. The company had revenue of $3.65 billion for the quarter, compared to analysts’ expectations of $3.70 billion. Aramark had a return on equity of 19.29% and a net margin of 2.37%. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period in the previous year, the business posted $0.49 earnings per share. equities analysts forecast that Aramark will post 1.77 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Thursday, December 7th. Stockholders of record on Monday, November 27th will be issued a dividend of $0.105 per share. This is a boost from Aramark’s previous quarterly dividend of $0.10. This represents a $0.42 annualized dividend and a dividend yield of 1.05%. The ex-dividend date of this dividend is Friday, November 24th. Aramark’s payout ratio is 29.93%.

A number of research analysts have issued reports on ARMK shares. BidaskClub upgraded Aramark from a “hold” rating to a “buy” rating in a research report on Wednesday, October 18th. Nomura lifted their target price on Aramark from $45.00 to $47.00 and gave the company a “buy” rating in a research report on Tuesday, October 17th. Royal Bank Of Canada reiterated a “buy” rating on shares of Aramark in a research report on Thursday, October 5th. Morgan Stanley lifted their target price on Aramark from $39.00 to $40.00 and gave the company an “equal weight” rating in a research report on Thursday, August 10th. Finally, Barclays PLC reiterated a “hold” rating and issued a $45.00 target price on shares of Aramark in a research report on Thursday, October 19th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. Aramark presently has a consensus rating of “Buy” and a consensus price target of $44.83.

Aramark Company Profile

Aramark is a global provider of food, facilities and uniform services to education, healthcare, business and industry, and sports, leisure and corrections clients. The Company operates through three segments: Food and Support Services North America (FSS North America), Food and Support Services International (FSS International), and Uniform and Career Apparel (Uniform).

Want to see what other hedge funds are holding ARMK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aramark (NYSE:ARMK).

Institutional Ownership by Quarter for Aramark (NYSE:ARMK)

Receive News & Ratings for Aramark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aramark and related companies with MarketBeat.com's FREE daily email newsletter.